HAARTbeat Article

HAART Aortic Valve Repair Technologies

Conditions Associated with Annular Dilatation and Aortic Insufficiency

The HAART Aortic Valve Repair Device reduces annular dilatation and recreates normal leaflet coaptation geometry through internal geometric ring annuloplasty. This new capability greatly expands the variety of treatable pathologies that cause aortic insufficiency and/or annular dilatation. No longer is aortic valve repair limited to patients with aortic root aneurysms.

We’ve worked closely with Dr. Scott Rankin to group the various valve disorders that have already been successfully treated with the HAART devices.

Primary annular dilatation with leaflet defects (left) and ascending and root aneurysms

Primary annular dilatation with leaflet defects (left) and ascending and root aneurysms (right)

Primary Annular Dilatation with Leaflet Defects


AI with Concomitant Procedures

Selected Aortic Stenosis

Revision of Previous Valve-Sparing Surgery

Bicuspid Aortic Valve (BAV) Defects

Complex Congenital Defects

  1. Dilated Ross Autograft with AI
  2. VSD with AI
  3. LVOT Membrane with AI
  4. TGA s/p Arterial Switch with Root Aneurysm and AI
  5. Congenital Aortic Root Aneurysm
  6. Truncus Valves with AI
  7. Quadricuspid with AI

Key messages:

  • HAART is applicable to a wide variety of pathologies that cause aortic insufficiency.
  • HAART standardizes aortic valve repair across the various pathologies through a repeatable and predictable technique.

Accessible aortic valve repair is now a reality with a well-defined patient population. The design of the HAART Aortic Annuloplasty Device enables a simple approach that, at last, brings standardization to this traditionally complex technical procedure. Aortic valve repair has been demonstrated to provide good long-term results with low rates of valve-related events as well as better quality of life.[1,2,3,4]

Now, the HAART Aortic Annuloplasty Devices make aortic valve repair a more standardized and predictable procedure that is applicable to a wide variety of patients with aortic insufficiency. Please take time to educate the referring physicians and make them aware of this exciting new option.

  1. Baumgartner H, Falk V, Bax JJ, et al. 2017 ESC/EACTS Guidelines for the management of valvular heart disease. Eur Heart J. 2017 Sep 21;38(36):2739-2791.
  2. Aicher D, Fries R, Rodionycheva S, et al. Aortic valve repair leads to a low incidence of valve-related complications. Eur J Cardiothorac Surg. 2010 Jan;37(1):127-32.
  3. de Meester C, Pasquet A, Gerber BL, et al. Valve repair improves the outcome of surgery for chronic severe aortic regurgitation: a propensity score analysis. J Thorac Cardiovasc Surg. 2014 Nov;148(5):1913-20.
  4. Price J, De Kerchove L, Glineur D, et al. Risk of valve-related events after aortic valve repair. Ann Thorac Surg. 2013 Feb;95(2):606-12.

About BioStable Science & Engineering
BioStable Science & Engineering is a cardiovascular device company focused on developing and commercializing proprietary valve repair technologies that provide an alternative to valve replacement for patients with aortic valve disease. The company’s HAART Aortic Repair Technologies are designed to simplify and standardize aortic valve repair, enabling surgeons to offer the recognized clinical benefits of valve repair to patients undergoing surgical correction of aortic insufficiency or aortic root aneurysm.

Please contact us for more information.